Answers are grounded in this paper and cite their sources.
Shows restrictive intravenous fluids do not reduce 90-day mortality in ICU septic shock patients, indicating standard fluid therapy remains a reasonable clinical approach.
Among adult patients with septic shock in the ICU, intravenous fluid restriction did not result in fewer deaths at 90 days than standard intravenous fluid therapy. (Funded by the Novo Nordisk Foundation and others; CLASSIC ClinicalTrials.gov number, NCT03668236.).
No takes yet. Share an insight, caveat, or question.
Meyhoff et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: